Heron Therapeutics
HRTX
HRTX
160 hedge funds and large institutions have $330M invested in Heron Therapeutics in 2024 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 46 increasing their positions, 46 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
6% more funds holding
Funds holding: 151 → 160 (+9)
4.14% more ownership
Funds ownership: 75.24% → 79.38% (+4.1%)
0% more repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 46
Holders
160
Holding in Top 10
4
Calls
$4.7M
Puts
$391K
Top Buyers
| 1 | +$11.6M | |
| 2 | +$5.35M | |
| 3 | +$3.89M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
+$2.78M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$1.56M |
Top Sellers
| 1 | -$9.12M | |
| 2 | -$2.39M | |
| 3 | -$2.01M | |
| 4 |
MAM
Monaco Asset Management
Monaco
|
-$1.14M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$621K |